Hypermethylation of the and Promoters in Osteoporosis: Potential Biomarkers for Early Diagnosis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Liu J, Jiang J, Li Y, Chen Q, Yang T, Lei Y Front Endocrinol (Lausanne). 2024; 15:1439255.
PMID: 39296716 PMC: 11409249. DOI: 10.3389/fendo.2024.1439255.
References
1.
Majtan T, Hulkova H, Park I, Krijt J, Kozich V, Bublil E
. Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria. FASEB J. 2017; 31(12):5495-5506.
PMC: 5690381.
DOI: 10.1096/fj.201700565R.
View
2.
Marini F, Cianferotti L, Brandi M
. Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?. Int J Mol Sci. 2016; 17(8).
PMC: 5000726.
DOI: 10.3390/ijms17081329.
View
3.
Xiao W, He J, Zhang H, Hu W, Gu J, Yue H
. ALOX12 polymorphisms are associated with fat mass but not peak bone mineral density in Chinese nuclear families. Int J Obes (Lond). 2010; 35(3):378-86.
PMC: 3061002.
DOI: 10.1038/ijo.2010.157.
View
4.
Hao Y, He D, Gao Y, Fang L, Zhang P, Lu K
. Association of Hydrogen Sulfide with Femoral Bone Mineral Density in Osteoporosis Patients: A Preliminary Study. Med Sci Monit. 2021; 27:e929389.
PMC: 7970661.
DOI: 10.12659/MSM.929389.
View
5.
Al-E-Ahmad A, Parsian H, Fathi M, Faghihzadeh S, Hosseini S, Nooreddini H
. ALOX12 gene polymorphisms and serum selenium status in elderly osteoporotic patients. Adv Clin Exp Med. 2018; 27(12):1717-1722.
DOI: 10.17219/acem/75689.
View